Gary K. Smith

3.7k total citations · 1 hit paper
47 papers, 2.5k citations indexed

About

Gary K. Smith is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Gary K. Smith has authored 47 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 7 papers in Cell Biology and 6 papers in Oncology. Recurrent topics in Gary K. Smith's work include Biochemical and Molecular Research (11 papers), Metabolism and Genetic Disorders (4 papers) and Sphingolipid Metabolism and Signaling (4 papers). Gary K. Smith is often cited by papers focused on Biochemical and Molecular Research (11 papers), Metabolism and Genetic Disorders (4 papers) and Sphingolipid Metabolism and Signaling (4 papers). Gary K. Smith collaborates with scholars based in United States, United Kingdom and Canada. Gary K. Smith's co-authors include Charles A. Nichol, David S. Duch, John F. Reinhard, Daniel F. Hassler, Yusuf A. Hannun, Stephen J. Benkovic, Mathew J. Reeves, Thomas W. Smith, Μ. D. Salman and Ralph A. Kelly and has published in prestigious journals such as Journal of Biological Chemistry, Annual Review of Biochemistry and Blood.

In The Last Decade

Gary K. Smith

47 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

BIOSYNTHESIS AND METABOLISM OF TETRAHYDROBIOPTERIN AND MOLYBDOPTERIN

1985 489 citations Charles A. Nichol, Gary K. Smith et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gary K. Smith United States	24	1.5k	392	346	313	233	47	2.5k
L. Takemoto United States	33	3.4k 2.3×	825 2.1×	646 1.9×	444 1.4×	85 0.4×	143	3.8k
Howard S. Tager United States	43	3.1k 2.1×	417 1.1×	116 0.3×	436 1.4×	220 0.9×	110	5.7k
Lawrence J. Alvarez United States	13	1.6k 1.1×	132 0.3×	66 0.2×	267 0.9×	107 0.5×	34	2.4k
Marie‐Claire Orgebin‐Crist United States	40	1.7k 1.1×	188 0.5×	51 0.1×	339 1.1×	70 0.3×	115	4.5k
Francisco Centeno Spain	20	958 0.7×	273 0.7×	31 0.1×	207 0.7×	119 0.5×	38	1.9k
Usha P. Andley United States	34	3.2k 2.2×	608 1.6×	482 1.4×	625 2.0×	72 0.3×	104	3.7k
John G. Pierce United States	37	2.2k 1.5×	340 0.9×	36 0.1×	288 0.9×	83 0.4×	99	5.7k
M.R. Sairam Canada	40	2.5k 1.7×	378 1.0×	21 0.1×	163 0.5×	55 0.2×	208	6.6k
R.D. Jolly New Zealand	35	1.5k 1.0×	2.4k 6.0×	233 0.7×	797 2.5×	55 0.2×	115	3.5k
Shigemi Matsuyama United States	36	4.3k 2.9×	292 0.7×	150 0.4×	447 1.4×	81 0.3×	72	5.7k

Countries citing papers authored by Gary K. Smith

Since Specialization

Citations

This map shows the geographic impact of Gary K. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary K. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary K. Smith more than expected).

Fields of papers citing papers by Gary K. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary K. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary K. Smith. The network helps show where Gary K. Smith may publish in the future.

Co-authorship network of co-authors of Gary K. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Gary K. Smith. A scholar is included among the top collaborators of Gary K. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary K. Smith. Gary K. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Udoh, Utibe‐Abasi S., Moumita Banerjee, Pradeep Rajan, et al.. (2022). Tumor-Suppressor Role of the α1-Na/K-ATPase Signalosome in NASH Related Hepatocellular Carcinoma. International Journal of Molecular Sciences. 23(13). 7359–7359. 9 indexed citations

Gilmartin, Aidan G., Maureen R. Bleam, Mark C. Richter, et al.. (2009). Distinct Concentration-Dependent Effects of the Polo-like Kinase 1–Specific Inhibitor GSK461364A, Including Differential Effect on Apoptosis. Cancer Research. 69(17). 6969–6977. 100 indexed citations

Erskine, Symon G., et al.. (2007). Biochemical characterization of GSK461364: A novel, potent, and selective inhibitor of Polo-like kinase-1 (Plk1). Cancer Research. 67. 3257–3257. 4 indexed citations

Khandekar, Sanjay, Tracey Yi, Susan Chen, et al.. (2006). Expression, Purification, and Characterization of an Enzymatically Active Truncated Human Rho-Kinase I (ROCK I) Domain Expressed in Sf-9 Insect Cells. Protein and Peptide Letters. 13(4). 369–376. 4 indexed citations

Orsini, James A., et al.. (2003). Odds of moderate or severe gastric ulceration in racehorses receiving antiulcer medications. Journal of the American Veterinary Medical Association. 223(3). 336–339. 20 indexed citations

Drobatz, Kenneth J. & Gary K. Smith. (2003). Evaluation of risk factors for bite wounds inflicted on caregivers by dogs and cats in a veterinary teaching hospital. Journal of the American Veterinary Medical Association. 223(3). 312–316. 26 indexed citations

Donaldson, Mark T., et al.. (2002). Treatment with Pergolide or Cyproheptadine of Pituitary Pars Intermedia Dysfunction (Equine Cushing's Disease). Journal of Veterinary Internal Medicine. 16(6). 742–746. 102 indexed citations

Hassler, Daniel F., Ronald M. Laethem, & Gary K. Smith. (2000). [20] A high throughput sphingomyelinase assay. Methods in enzymology on CD-ROM/Methods in enzymology. 311. 176–184. 7 indexed citations

Liu, Bin, Daniel F. Hassler, Gary K. Smith, Kurt Weaver, & Yusuf A. Hannun. (1998). Purification and Characterization of a Membrane Bound Neutral pH Optimum Magnesium-dependent and Phosphatidylserine-stimulated Sphingomyelinase from Rat Brain. Journal of Biological Chemistry. 273(51). 34472–34479. 112 indexed citations

10.

Smith, Gary K., Todd A. Blumenkopf, Michael Cory, et al.. (1997). Toward Antibody-directed Enzyme Prodrug Therapy with the T268G Mutant of Human Carboxypeptidase A1 and Novel in VivoStable Prodrugs of Methotrexate. Journal of Biological Chemistry. 272(25). 15804–15816. 42 indexed citations

11.

Simmons, William W., Dan Ungureanu-Longrois, Gary K. Smith, Thomas W. Smith, & Ralph A. Kelly. (1996). Glucocorticoids Regulate Inducible Nitric Oxide Synthase by Inhibiting Tetrahydrobiopterin Synthesis and L-Arginine Transport. Journal of Biological Chemistry. 271(39). 23928–23937. 160 indexed citations

12.

Laethem, Ronald M., Todd A. Blumenkopf, Michael Cory, et al.. (1996). Expression and Characterization of Human Pancreatic Preprocarboxypeptidase A1 and Preprocarboxypeptidase A2. Archives of Biochemistry and Biophysics. 332(1). 8–18. 21 indexed citations

13.

Jansen, Marilyn, Michael Dykstra, Jeremy N. Stables, et al.. (1994). Effect of purine synthesis inhibition on WiDr spheroids in vitro or on WiDr or colon 38 tumors in vivo. Biochemical Pharmacology. 47(6). 1067–1078. 7 indexed citations

14.

Barrett, Linda, et al.. (1994). Destruction of WiDr multicellular tumor spheroids with the novel thymidylate synthase inhibitor 1843U89 at physiological thymidine concentrations. Cancer Chemotherapy and Pharmacology. 33(6). 455–459. 13 indexed citations

15.

Bigham, Eric C., et al.. (1992). Synthesis and biological activity of open-chain analogs of 5,6,7,8-tetrahydrofolic acid-potential antitumor agents. Journal of Medicinal Chemistry. 35(8). 1399–1410. 26 indexed citations

16.

Kelley, James L., Ed W. McLean, Mark Edelstein, et al.. (1990). Synthesis and biological activity of an acyclic analog of 5,6,7,8-tetrahydrofolic acid, N-[4-[[3-(2,4-diamino-1,6-dihydro-6-oxo-5-pyrimidinyl)propyl]amino]benzoyl]-L-glutamic acid. Journal of Medicinal Chemistry. 33(2). 561–567. 24 indexed citations

17.

Smith, Gary K., Thomas J. Monaco, R. Rigual, et al.. (1990). Activity of an NAD-dependent 5,10-methylenetetrahydrofolate dehydrogenase in normal tissue, neoplastic cells, and oncogene-transformed cells. Archives of Biochemistry and Biophysics. 283(2). 367–371. 23 indexed citations

18.

Smith, Gary K., et al.. (1988). Inhibition of chicken liver 5-aminoimidazole-4-carboxamide ribonucleotide transformylase by 5,8-dideaza analogues of folic acid. Biochemical Pharmacology. 37(3). 449–451. 3 indexed citations

19.

Smith, Gary K., et al.. (1987). On the substrate specificity of bovine liver dihydrofolate reductase: New unconjugated dihydropterin substrates. Archives of Biochemistry and Biophysics. 254(2). 416–420. 6 indexed citations

20.

Smith, Gary K., Patricia A. Benkovic, & Stephen J. Benkovic. (1981). l(-)-10-Formyltetrahydrofolate is the cofactor for glycinamide ribonucleotide transformylase from chicken liver. Biochemistry. 20(14). 4034–4036. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact